OptiBiotix Health (LON:OPTI) Announces Quarterly Earnings Results

OptiBiotix Health (LON:OPTI) released its quarterly earnings data on Thursday. The company reported GBX (3.84) EPS for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 2.27% and a negative net margin of 16.59%.The business had revenue of GBX 117 million during the quarter.

OptiBiotix Health Stock Performance

LON:OPTI opened at GBX 6.30 on Thursday. The stock has a 50-day simple moving average of GBX 5.32 and a two-hundred day simple moving average of GBX 6.36. OptiBiotix Health has a 52-week low of GBX 4.50 and a 52-week high of GBX 15. The firm has a market capitalization of £6.51 million, a PE ratio of -209.97 and a beta of 1.71.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.